KINGDON CAPITAL MANAGEMENT, L.L.C. - Q4 2015 holdings

$2.06 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 114 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 66.3% .

 Value Shares↓ Weighting
SPY SellSPDR S&P 500 ETF TRput$152,903,000
-0.3%
750,000
-6.2%
7.44%
+0.6%
IWM SellISHARES TRput$115,436,000
-47.1%
1,025,000
-48.8%
5.61%
-46.7%
VC SellVISTEON CORP$57,957,000
-18.4%
506,179
-27.9%
2.82%
-17.7%
CDK SellCDK GLOBAL INC$50,545,000
-4.7%
1,064,775
-4.1%
2.46%
-3.9%
HZNP SellHORIZON PHARMA PLCcall$30,555,000
-26.8%
1,410,000
-33.0%
1.49%
-26.1%
CFG SellCITIZENS FINL GROUP INCcall$23,571,000
-1.2%
900,000
-10.0%
1.15%
-0.3%
HRTX SellHERON THERAPEUTICS INCcall$21,360,000
-42.8%
800,000
-47.7%
1.04%
-42.3%
XLI SellSELECT SECTOR SPDR TRput$21,204,000
-43.3%
400,000
-46.7%
1.03%
-42.8%
SellEMERGENT BIOSOLUTIONS INCnote 2.875% 1/1$16,506,000
+11.9%
12,000,000
-7.7%
0.80%
+12.9%
FLXN SellFLEXION THERAPEUTICS INC$14,836,000
+19.5%
769,903
-7.9%
0.72%
+20.4%
TGT SellTARGET CORP$13,724,000
-60.8%
189,010
-57.5%
0.67%
-60.5%
AGN SellALLERGAN PLC$12,721,000
-27.4%
40,706
-36.9%
0.62%
-26.7%
DPRX SellDIPEXIUM PHARMACEUTICALS INC$10,921,000
-20.5%
975,099
-0.6%
0.53%
-19.8%
ETFC SellE TRADE FINANCIAL CORPcall$8,892,000
-51.8%
300,000
-57.1%
0.43%
-51.4%
VNDA SellVANDA PHARMACEUTICALS INC$8,701,000
-60.3%
934,568
-51.9%
0.42%
-60.0%
HCA SellHCA HOLDINGS INC$7,632,000
-71.0%
112,852
-66.9%
0.37%
-70.8%
VIRT SellVIRTU FINL INCcl a$7,358,000
-10.8%
325,000
-9.7%
0.36%
-10.1%
VSAR SellVERSARTIS INC$6,458,000
-18.5%
521,244
-24.2%
0.31%
-17.8%
EBS SellEMERGENT BIOSOLUTIONS INC$4,807,000
-58.6%
120,142
-70.5%
0.23%
-58.2%
KMPH SellKEMPHARM INC$4,039,000
-22.9%
203,390
-24.8%
0.20%
-22.5%
LPCN SellLIPOCINE INC NEW$3,153,000
-9.7%
243,830
-17.3%
0.15%
-8.9%
NVLS SellNIVALIS THERAPEUTICS INC$3,093,000
-43.1%
399,663
-4.6%
0.15%
-42.7%
EXEL SellEXELIXIS INC$3,041,000
-33.9%
539,130
-34.3%
0.15%
-33.3%
MPWR SellMONOLITHIC PWR SYS INC$2,917,000
-29.2%
45,792
-43.1%
0.14%
-28.6%
IL SellINTRALINKS HLDGS INC$2,875,000
-0.1%
317,032
-8.6%
0.14%
+0.7%
ANAC SellANACOR PHARMACEUTICALS INCcall$2,824,000
-76.0%
25,000
-75.0%
0.14%
-75.9%
MDWD SellMEDIWOUND LTD$1,576,000
-34.1%
184,590
-41.1%
0.08%
-33.0%
SGYPQ SellSYNERGY PHARMACEUTICALS DEL$1,301,000
-27.8%
229,420
-32.5%
0.06%
-27.6%
ABMD SellABIOMED INC$1,258,000
-60.0%
13,930
-58.9%
0.06%
-59.9%
TKAI SellTOKAI PHARMACEUTICALS INC$767,000
-88.7%
87,983
-86.6%
0.04%
-88.8%
EXEL ExitEXELIXIS INCcall$0-100,000
-100.0%
-0.03%
GBT ExitGLOBAL BLOOD THERAPEUTICS IN$0-20,200
-100.0%
-0.04%
ITEK ExitINOTEK PHARMACEUTICALS CORP$0-115,000
-100.0%
-0.05%
AAPL ExitAPPLE INC$0-11,252
-100.0%
-0.06%
RPRX ExitREPROS THERAPEUTICS INCcall$0-200,000
-100.0%
-0.07%
ExitAEGERION PHARMACEUTICALS INCnote 2.000% 8/1$0-2,000,000
-100.0%
-0.07%
ITCI ExitINTRA CELLULAR THERAPIES INC$0-40,000
-100.0%
-0.08%
SUNEQ ExitSUNEDISON INC$0-225,000
-100.0%
-0.08%
UHS ExitUNIVERSAL HLTH SVCS INCcl b$0-13,100
-100.0%
-0.08%
OVAS ExitOVASCIENCE INCcall$0-200,000
-100.0%
-0.08%
CIVI ExitCIVITAS SOLUTIONS INC$0-74,050
-100.0%
-0.08%
CLVS ExitCLOVIS ONCOLOGY INC$0-20,600
-100.0%
-0.09%
NUVA ExitNUVASIVE INC$0-40,500
-100.0%
-0.09%
CEMP ExitCEMPRA INCput$0-100,000
-100.0%
-0.13%
SRPT ExitSAREPTA THERAPEUTICS INCcall$0-100,000
-100.0%
-0.16%
VNDA ExitVANDA PHARMACEUTICALS INCcall$0-300,000
-100.0%
-0.16%
LNKD ExitLINKEDIN CORPput$0-18,900
-100.0%
-0.17%
ESGC ExitEROS INTL PLC$0-150,000
-100.0%
-0.20%
LXRX ExitLEXICON PHARMACEUTICALS INCcall$0-400,000
-100.0%
-0.21%
PBR ExitPETROLEO BRASILEIRO SA PETROput$0-1,110,000
-100.0%
-0.23%
VDTH ExitVIDEOCON D2H LTDadr$0-530,000
-100.0%
-0.25%
LLY ExitLILLY ELI & CO$0-61,100
-100.0%
-0.25%
TYFDL ExitTYSON FOODS INCunit 99/99/9999$0-100,000
-100.0%
-0.25%
NVO ExitNOVO-NORDISK A Sput$0-100,000
-100.0%
-0.26%
OAK ExitOAKTREE CAP GROUP LLCunit cl a$0-119,550
-100.0%
-0.28%
JKS ExitJINKOSOLAR HLDG CO LTDsponsored adr$0-310,000
-100.0%
-0.33%
TMUSP ExitT MOBILE US INCconv pfd ser a$0-100,000
-100.0%
-0.33%
DISH ExitDISH NETWORK CORPcl a$0-120,000
-100.0%
-0.34%
NBL ExitNOBLE ENERGY INC$0-252,746
-100.0%
-0.37%
HRB ExitBLOCK H & R INC$0-213,334
-100.0%
-0.37%
IDTI ExitINTEGRATED DEVICE TECHNOLOGY$0-390,000
-100.0%
-0.38%
MDLZ ExitMONDELEZ INTL INCcl a$0-200,238
-100.0%
-0.40%
FTNT ExitFORTINET INCput$0-200,000
-100.0%
-0.41%
TWTR ExitTWITTER INCput$0-319,000
-100.0%
-0.41%
TSN ExitTYSON FOODS INCput$0-200,000
-100.0%
-0.42%
SUNEQ ExitSUNEDISON INCcall$0-1,250,000
-100.0%
-0.43%
AVGO ExitAVAGO TECHNOLOGIES LTD$0-73,807
-100.0%
-0.44%
HLS ExitHEALTHSOUTH CORP$0-244,800
-100.0%
-0.45%
KMB ExitKIMBERLY CLARK CORP$0-96,000
-100.0%
-0.50%
XBI ExitSPDR SERIES TRUSTput$0-200,000
-100.0%
-0.60%
TILE ExitINTERFACE INC$0-687,252
-100.0%
-0.74%
AWI ExitARMSTRONG WORLD INDS INC NEW$0-368,777
-100.0%
-0.85%
AWHHF ExitALLIED WRLD ASSUR COM HLDG A$0-472,955
-100.0%
-0.87%
FAST ExitFASTENAL COput$0-500,000
-100.0%
-0.88%
XBI ExitSPDR SERIES TRUSTcall$0-300,000
-100.0%
-0.90%
NFX ExitNEWFIELD EXPL CO$0-569,546
-100.0%
-0.90%
KAR ExitKAR AUCTION SVCS INC$0-553,270
-100.0%
-0.95%
XLV ExitSELECT SECTOR SPDR TRcall$0-300,000
-100.0%
-0.96%
KRE ExitSPDR SERIES TRUSTput$0-500,000
-100.0%
-0.99%
THC ExitTENET HEALTHCARE CORPcall$0-580,000
-100.0%
-1.03%
CBRE ExitCBRE GROUP INCcl a$0-744,761
-100.0%
-1.15%
TSN ExitTYSON FOODS INCcl a$0-567,245
-100.0%
-1.18%
DVN ExitDEVON ENERGY CORP NEW$0-716,952
-100.0%
-1.28%
XHB ExitSPDR SERIES TRUSTput$0-850,000
-100.0%
-1.40%
PYPL ExitPAYPAL HLDGS INC$0-1,236,570
-100.0%
-1.85%
ADBE ExitADOBE SYS INC$0-483,246
-100.0%
-1.92%
AXTA ExitAXALTA COATING SYS LTD$0-2,304,661
-100.0%
-2.82%
HCA ExitHCA HOLDINGS INCcall$0-755,000
-100.0%
-2.82%
GOOGL ExitGOOGLE INCcl a$0-100,091
-100.0%
-3.08%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings